| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Cohen Mark S is a Director at AKTX. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $200K at current prices.
Cohen Mark S's largest disclosed position is in AKTX as Director, worth about $200K. Net of sales, the recent Form 4 record there shows accumulation of 1,055,600 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2015 | AKTX Akari Therapeutics Plc | Director | Buy | 1,055,600 | $0.19 | $200,036.20 | New |